Condition
ALL, Adult B Cell
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Kur502
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 1 (1)
Trial Status
Unknown1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Kur5021
Active Sponsors
- Athenex, Inc.1
Top Investigators
Baylor College of Medicine
Related Conditions
- All Childhood1
- Bcell Lymphoma1
- Dlbcl Diffuse Large B Cell Lymphoma1
- Cllsll1
- Nhl Relapsed Adult1